CDK4/6-IN-3 |
Catalog No.GC35634 |
CDK4/6-IN-3은 각각 <0.3 nM 및 2.2 nM의 Kis를 갖는 뇌 침투 CDK4/CDK6 억제제입니다. CDK4/6-IN-3은 110nM의 Ki로 CDK1을 억제합니다. CDK4/6-IN-3은 교모세포종의 치료에 사용할 수 있습니다.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 2366237-37-6
Sample solution is provided at 25 µL, 10mM.
CDK4/6-IN-3 is a brain-penetrant CDK4/CDK6 inhibitor with Kis of <0.3 nM and 2.2 nM, respectively. CDK4/6-IN-3 inhibits CDK1 with a Ki of 110 nM. CDK4/6-IN-3 can be used for the treatment of glioblastoma[1]. CDK4|0.3 nM (Ki)|CDK6|2.2 nM (Ki)|CDK1|110 nM (Ki)
CDK4/6-IN-3 (Compound 24) inhibits MCF7 and BT549 cell lines proliferation with EC50s of 30 nM and 2.1 μM, respectively[1].
[1]. Bronner SM, et al. Design of a brain-penetrant CDK4/6 inhibitor for glioblastoma. Bioorg Med Chem Lett. 2019 Aug 15;29(16):2294-2301.
Average Rating: 5
(Based on Reviews and 25 reference(s) in Google Scholar.)GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *